Professor Philippe Roingeard

Professor Philippe Roingeard

Dr Philippe Roingeard obtained a Pharm D (1984) and a PhD in Cell Biology and Virology (1988) at the François Rabelais University in Tours, France, prior to get a position of Research Associate in the Department of Cancer Biology at the Harvard School of Public Health (1988-1991). He is currently professor of Cell Biology at the François Rabelais University and hospital practitioner at the University Hospital in Tours. He is the head of the research team INSERM U 966 “Morphogenesis and antigenicty of HIV and hepatitis viruses” in Tours. He has recently developed the concept of a bivalent vaccine against hepatitis B and hepatitis C viruses (http://cvscience.aviesan.fr/cv/255/philippe-roingeard).

Upcoming Events
Biologics Manufacturing Asia 2019 26 – 28 February 2019, Singapore

In 2019, 400+ biomanufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities across Singapore, South Korea, Taiwan, Japan, Australia, India, Indonesia, Malaysia,  and China  will convene on the best manufacturing practices in order to have access to faster, cheaper and better biologic drugs!

.. Read More

Biologistics World Asia 2019 26 – 28 February 2019, Singapore

Biologistics World Asia is  THE  ONLY  event in the Asia-Pacific region that focuses on logistics and supply chain of biopharmaceuticals! The event will bring  150+  high-profile attendees together to discuss,  debate and brainstorm on the most pertinent issues affecting the biopharmaceutical logistics network.

.. Read More

 

Biologics World Nordic 2019 5 – 7 March 2019, Stockholm, Sweden

Biologistics World Asia is  THE  ONLY  event in the Asia-Pacific region that focuses on logistics and supply chain of biopharmaceuticals! The event will bring  150+  high-profile attendees together to discuss,  debate and brainstorm on the most pertinent issues affecting the biopharmaceutical logistics network.

.. Read More